Despite enormous evolution in oncopharmacology, the non-small cell lung carcinoma
(NSCLC) is still among the most aggressive and prevalent types of cancer. Late diagnosis …

Exosomes are the phospholipid-membrane-bound subpopulation of extracellular vesicles
derived from the plasma membrane. The main activity of exosomes is cellular …

Lung cancer is often diagnosed at an advanced stage and has a poor prognosis.
Conventional treatments are not effective for metastatic lung cancer therapy. Although some …

This study has demonstrated improved methods for isolating exosomes from non-small lung
cancer cells, which address the problems characterized by exosome morphological and …

Lung cancer is the leading cause of cancer-associated deaths accounting for 24% of all
cancer deaths. As a crucial phase of tumor progression, lung cancer metastasis is linked to …

Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases,
and it is one of the leading causes of cancer death in both men and women worldwide due …

Tumor microenvironment (TME) plays an integral part in the biology of cancer, participating
in tumor initiation, progression, and response to therapy. Exosome is an important part of …

Lung cancer is one of the most common malignant tumors, and its death rate is much higher
than that of colon, kidney, breast, and prostate cancers, and its 5-year survival rate is only …

Lung cancer is the leading cause of cancer‐related death worldwide due to diagnosis in the
advanced stage and drug resistance in the subsequent treatments. Development of novel …

Exosomes are described as nanoscale extracellular vesicles (EVs) secreted by multiple cell
types and extensively distributed in various biological fluids. They contain multifarious …